Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
04/13/1992 | CA2052686A1 Use of a retinoid |
04/11/1992 | WO1992007072A1 Method of inhibiting transcription utilizing nuclear receptors |
04/11/1992 | CA2093811A1 Method of inhibiting transcription utilizing nuclear receptors |
04/08/1992 | EP0479524A1 Method to reduce intraocular pressure without causing miosis |
04/08/1992 | EP0479518A1 Compositions for topical application |
04/08/1992 | EP0479479A1 Imadazole angiotensin II antagonists incorporating acidic functional groups |
04/06/1992 | WO1992005698A1 Regulation of immunoglobulin production by interleukin-9 |
04/02/1992 | WO1992004901A1 Uracil reductase inactivators |
04/02/1992 | WO1992004893A1 Non-aqueous liquid oral suspensions |
04/02/1992 | CA2390654A1 Uracil reductase inactivators |
04/02/1992 | CA2052517A1 Imidazole angiotensin ii antagonists incorporating acidic functional groups |
04/02/1992 | CA2052438A1 Method to reduce intraocular pressure without causing miosis |
04/01/1992 | EP0477625A1 Method for preventing or treating anxiety employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
04/01/1992 | EP0477624A1 Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
03/31/1992 | CA1298201C Method and compositions for treating obesity, depression, drug abuse and narcolepsy |
03/29/1992 | WO1992005783A1 Ibuprofen-antihistamine combinations |
03/29/1992 | CA2092566A1 Ibuprofen-antihistamine combinations |
03/27/1992 | CA2051261A1 Cardiopulmonary bypass and organ transplant using a potassium channel activator |
03/25/1992 | EP0477050A2 LPS-producing bacteria, LPSs, and LPS-containing medicines and veterinary medicines |
03/25/1992 | EP0476711A2 Use of 5-fluorouracil for the treatment of AIDS |
03/24/1992 | US5098910 Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
03/24/1992 | US5098909 5-ht3 receptor antagonists for treatment of cough and bronchoconstriction |
03/24/1992 | US5098889 Cognition activators, angiotensin converting enzyme inhibitors |
03/19/1992 | WO1992004052A1 Modified antibodies with controlled clearance time |
03/19/1992 | WO1992004027A1 Pharmaceutical compositions for use in treating aids |
03/19/1992 | WO1992004022A1 Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders |
03/19/1992 | WO1992004008A1 Composition for treating ocular pain |
03/19/1992 | CA2073003A1 Composition for treating ocular pain |
03/18/1992 | EP0216786B1 Purification, production and use of tumor necrosis factors |
03/18/1992 | CA2050043A1 Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
03/18/1992 | CA2050042A1 Method for preventing or treating anxiety employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
03/18/1992 | CA2049506A1 Method for preventing or inhibiting loss of cognitive function employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
03/17/1992 | US5096908 Method of inhibiting gastric acid secretion |
03/17/1992 | US5096892 Arylsulfatase inhibition and potentiation of angiostatic steroids and heparin |
03/17/1992 | US5096712 Administering tyrosine and synergistic indirect-acting sympathomimetic drug |
03/17/1992 | CA1297407C Pharmaceutical which can be administered nasally, a process for it preparation, and its use |
03/12/1992 | WO1992004021A1 Method for providing improved analgesic effect |
03/11/1992 | WO1992004040A1 Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide |
03/11/1992 | EP0473673A1 Method for protection from azt side effects and toxicity |
03/11/1992 | EP0422097A4 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo |
03/10/1992 | US5095027 Antiischemic |
03/10/1992 | CA1297024C Drug compositions stabilized against oxidation |
03/10/1992 | CA1297023C Stabilized drug composition containing ascorbic acid |
03/10/1992 | CA1297006C Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
03/05/1992 | WO1992004015A2 REGULATION OF T-CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
03/05/1992 | WO1992004014A2 REGULATION OF NEOPLASTIC CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
03/05/1992 | WO1992003165A1 New use of a monoclonal antibody |
03/05/1992 | WO1992003151A1 Uses of recombinant colony stimulating factor-1 |
03/05/1992 | WO1992003137A1 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss |
03/05/1992 | CA2090689A1 Regulation of t-cell proliferation via a novel 5htla receptor |
03/05/1992 | CA2090688A1 Regulation of neoplastic cell proliferation via a novel 5htla receptor |
03/04/1992 | EP0473442A1 A substituted pyrazine and its salts, compositions containing them and their use in medicine |
03/04/1992 | EP0472639A1 Accumulation of drugs into liposomes by a proton gradient |
03/04/1992 | EP0198893B1 Hair growth modification |
03/04/1992 | EP0180597B1 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
03/03/1992 | US5093475 Hindered linking agents derived from 2-iminothiolanes and methods |
03/03/1992 | US5093129 Method for treating addiction to a drug of abuse employing an ace inhibitor |
03/03/1992 | US5093115 Method of preparing activated killer monocytes for treating colorectal cancer |
03/03/1992 | CA1296633C Controlled release bases for pharmaceuticals |
03/03/1992 | CA1296630C Dual phase solvent carrier system |
03/01/1992 | CA2050264A1 Substituted pyrazine and its salts, compositions containing them and their use in medicine |
02/26/1992 | EP0472467A2 LPS-Containing analgesics and veterinary analgesics |
02/26/1992 | EP0471787A1 A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor |
02/25/1992 | US5091193 Zinc oxide, phytic acid and an ester of a fatty alcohol as anti-enzyme |
02/25/1992 | US5091171 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
02/21/1992 | CA2049533A1 Lps-containing analgesics and veterinary analgesics |
02/20/1992 | WO1992002229A1 Immunosuppressive compositions |
02/20/1992 | CA2088492A1 Immunosuppressive compositions |
02/19/1992 | EP0471084A1 Oil-in-water emulsion composition containing nonsteroidal antiphlogistic analgesic |
02/18/1992 | US5089508 Administering a phenylacetamidinopiperidine-2,6-dione |
02/18/1992 | US5089479 Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide |
02/18/1992 | CA1295998C Nucleosides and their use as antineoplastic agents |
02/18/1992 | CA1295944C Pharmaceutical composition with antiviral or antitumor activity |
02/13/1992 | DE4025499A1 Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen Use of antibodies BR55-2, derivatives thereof, and fragments conjugate on HIV infections |
02/12/1992 | EP0470667A1 Composition containing a 4-quinolone derivative complexed with a divalent metal ion |
02/12/1992 | EP0470117A1 Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions. |
02/11/1992 | US5087616 Linked by biodegradable polymer to epidermal growth factor |
02/11/1992 | US5087560 Monoclonal antibody for use in drug resistant cancers and production thereof |
02/11/1992 | US5087451 Treatment of periodontal disease |
02/05/1992 | EP0191772B1 Acid-cleavable compound |
02/04/1992 | US5086072 Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
02/04/1992 | US5086061 Use of beta blockers for the treatment of the progression of infantile axial myopia |
02/03/1992 | WO1992002253A1 INTERLEUKIN-4 AND INTERLEUKIN-1β SYNERGISTICALLY INDUCE VCAM-1 |
01/29/1992 | EP0468929A2 Stabilized pharmaceutical compositions |
01/29/1992 | EP0468555A1 Pharmaceutical composition for rectal administration of active principles exhibiting a prevalently topical medication action at the colon level |
01/29/1992 | EP0467957A1 Mercapto-acylamino acids |
01/29/1992 | EP0467932A1 Urokinase-type plasminogen activator receptor |
01/29/1992 | CN1058214A 1,3-oxathiolane nucleoside analogues |
01/28/1992 | WO1992002240A2 Novel methods and compositions for treatment of angiogenic diseases |
01/28/1992 | US5084274 Inhibition of arterial thrombotic occlusion or thromboembolism |
01/28/1992 | US5084267 Sustained release compositions for treating periodontal disease |
01/28/1992 | CA2082804A1 Methods and compositions for treatment of angiogenic diseases |
01/25/1992 | WO1992001469A1 A composition providing improved clearance of bioactive substances from the bloodstream |
01/25/1992 | CA2087971A1 Composition providing improved clearance of bioactive substances from the bloodstream |
01/23/1992 | WO1992000994A1 Growth-promoting agent |
01/23/1992 | WO1992000760A1 Method of treating neurological dysfunction using neurotransmitter enhances |
01/22/1992 | EP0467710A2 Method for treating Parkinson's disease employing the ATP-sensitive potassium channel blocker quinine |
01/22/1992 | EP0467709A2 Use of an ATP-sensitive potassium channel blocker to treat neuronal insult |
01/22/1992 | EP0467365A2 Use of a 5-hydroxytryptamine-3(5-HT3) receptor antagonist for the preparation of a pharmaceutical composition for treating urinary incontinence |
01/22/1992 | EP0466813A1 Active specific immunotherapy of adenocarcinomas producing immunosuppressive mucins |